9 results
#Diagnosis #EM #IM #PERC #Low #Risk #Pulmonary #Embolism #PulmonaryEmbolism #Algorithm #RebelEM
#Diagnosis #EM # ... IM #PERC #Low #Risk ... #Pulmonary #Embolism ... #PulmonaryEmbolism ... #Algorithm #RebelEM
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... Embolism • Provoked ... #PE #Pulmonary # ... #Algorithm #management ... #hematology #VTE
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... thrombosis; PE = pulmonary ... embolism; GI = ... anticoagulant; LMWH = low ... Anticoagulation #Management
Pulmonary Embolism Severeity Index - estimates 30d mortality #Diagnosis #Management #EM #IM #PCC #PESI #sPESI #risk
Pulmonary Embolism ... mortality #Diagnosis #Management ... #EM #IM #PCC #PESI ... #sPESI #risk #score ... #PE #PulmonaryEmbolism
HESTIA Criteria for Outpatient Pulmonary Embolism Treatment - Identifies low-risk PE patients safe for outpatient treatment
for Outpatient Pulmonary ... Embolism Treatment ... - Identifies low-risk ... #Diagnosis #Management ... #Criteria #PE #PulmonaryEmbolism
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... of recurrent VTE ... anticoagulant; LMWH, low-molecular-weight ... Anticoagulation #Management ... #Hematology #Oncology
A possible diagnostic algorithm for pulmonary embolism in pregnancy (equipose)

Given the variability in guidelines and equipoise
possible diagnostic algorithm ... for pulmonary embolism ... the benefits and risks ... Obstetrics #Radiology #PulmonaryEmbolism ... #VTE #Pregnancy
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
murmur 3/6) - Pulmonary ... event, follow ACC algorithm ... Orthopedic • Low ... • <3mo since VTE ... medical and surgical management
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
JAK2, CALR-calreticulin ... • Treatment algorithms ... appropriate only for low ... risk patients with ... #diagnosis #management